MedPath

TREMFYA

TREMFYA

Approved
DIN Number

02469758

Drug Class

Human

Market Date

Nov 27, 2017

Company
HC

Janssen Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02469758
AIG Number0159710001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
L04AC16 GUSELKUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification84:06.28
Health Canada Classification

ACTIVE INGREDIENTS (1)

GUSELKUMABActive
Strength: 100 MG / 1 ML
Monograph: GUSELKUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.